The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCIR.L Regulatory News (CIR)

  • There is currently no data for CIR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Block listing Interim Review

30 Sep 2021 15:15

RNS Number : 6058N
Circassia Group Plc
30 September 2021
 

Circassia Group plc

Block Listing Interim Review

 

Oxford, UK - 30 September 2021: Circassia Group plc (LSE: CIR), a medical device company focused on point of care asthma diagnosis and management, makes the following notification pursuant to Schedule Six of the AIM Rules for Companies regarding its existing block listing arrangements:

Name of the company:

Circassia Group plc

Name of relevant scheme:

1) Circassia EMI Share Option Scheme

2) Circassia 2007 Unapproved Share Scheme

3) Circassia 2014 Performance Share Plan Scheme

4) Circassia 2015 Performance Share Plan Scheme

5) Circassia 2016 Performance Share Plan Scheme

6) Circassia 2017 Performance Share Plan Scheme

7) Circassia 2020 Save As You Earn Scheme (UK)

Period of return:

From:

1 April 2021

To:

30 September 2021

Balance of unallotted securities under scheme(s) from previous return:

1) 700,750

2) 203,000

3) 76,676

4) 238,019

5) 709,543

6) 397,296

7) 0

Total 2,325,284

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

1) - 6) inclusive: Nil

7) 1,141,658

Less:  Number of securities issued/allotted under scheme(s) during period:

 

1) - 3) inclusive: Nil

4) (65,297)

5) (128,617)

6) (346,624)

7) (14,765)

Total (555,303)

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

1) 700,750

2) 203,000

3) 76,676

4) 172,722

5) 580,926

6) 50,672

7) 1,126,893

Total 2,911,639

Number and class of securities originally listed and the date of admission:

1) 2,600,000 - 20 March 2014

2) 516,000 - 1 June 2017

3) 500,000 - 1 June 2017

4) 400,000 - 21 May 2018

5) 930,000 - 1 July 2019

6) 980,000 - 22 May 2020

7) 1,141,658 - 1 April 2021 

 

Name of contact:

Sarah Duncan

Telephone number of contact:

01865 405 560

 

For further information, please contact:

Singer Capital Markets (Nominated Adviser and Broker)

Aubrey Powell / Jen Boorer / Hannah Woodley

Tel: +44 (0) 20 7496 3000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRMZGFLDGZGMZM
Date   Source Headline
24th Mar 20217:00 amRNSPreliminary Results
4th Feb 20218:30 amRNSPDMR Dealing - Transfer for Nil Consideration
29th Jan 20214:45 pmRNSTotal Voting Rights
12th Jan 20217:01 amRNSTrading Update
12th Jan 20217:00 amRNSChange of Nominated Adviser and Broker
31st Dec 20207:00 amRNSTotal Voting Rights
30th Nov 202012:34 pmRNSTotal Voting Rights
13th Nov 20207:00 amRNSBoard Appointment
10th Nov 20205:14 pmRNSChange of Registered Office
30th Oct 20207:00 amRNSTotal Voting Rights
2nd Oct 202011:19 amRNSHolding(s) in Company
30th Sep 20207:00 amRNSBlock listing Interim Review
30th Sep 20207:00 amRNSTotal Voting Rights
24th Sep 20203:14 pmRNSHolding(s) in Company
17th Sep 20207:00 amRNSInterim Results - Ended 30 June 2020
1st Sep 20207:00 amRNSGrant of Options
28th Aug 20207:00 amRNSTotal Voting Rights
21st Aug 202011:16 amRNSHolding(s) in Company
14th Aug 20207:00 amRNSGrant of options
10th Aug 202011:49 amRNSHolding(s) in Company
31st Jul 20207:00 amRNSTotal Voting Rights Update
23rd Jul 202010:52 amRNSResult of AGM
30th Jun 20207:00 amRNSTotal Voting Rights
17th Jun 202010:23 amRNSAnnual report and notice of AGM
16th Jun 20207:00 amRNSPreliminary Results
8th Jun 20201:12 pmRNSHolding(s) in Company
8th Jun 202011:42 amRNSHolding(s) in Company
2nd Jun 20207:00 amRNSEquity Financing Facility
29th May 20207:00 amRNSTotal Voting Rights
28th May 20207:00 amRNSCompletion of Transaction
27th May 20207:00 amRNSFurther re Transfer of Assets
18th May 20201:23 pmRNSBlock Listing Application
1st May 202011:12 amRNSGrant of options
1st May 202011:04 amRNSTotal Voting Rights
1st May 202010:32 amRNSChange of Name Effective
30th Apr 202010:34 amRNSResult of General Meeting
27th Apr 20204:27 pmRNSIssue of Equity
24th Apr 20203:58 pmRNSHolding(s) in Company
24th Apr 202012:32 pmRNSHolding(s) in Company
15th Apr 20202:13 pmRNSHolding(s) in Company
15th Apr 20207:00 amRNSPosting of circular and update on undertakings
14th Apr 20204:37 pmRNSHolding(s) in Company
14th Apr 20207:30 amRNSDirector/PDMR Shareholding
9th Apr 20207:00 amRNSProposed transfer of assets
31st Mar 20207:00 amRNSBlock listing Interim Review
31st Mar 20207:00 amRNSTotal Voting Rights
28th Feb 20207:03 amRNSFurther re Board appointment
28th Feb 20207:00 amRNSTotal Voting Rights
17th Feb 20202:17 pmRNSHolding(s) in Company
31st Jan 20207:00 amRNSTotal Voting Rights Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.